News > Discussing expedited approval pathway for Pfizer-BioNTech vaccine with government: Pfizer CEO

Discussing expedited approval pathway for Pfizer-BioNTech vaccine with government: Pfizer CEO

The Hindu Business Line | 03/05/2021 04:15 PM | Click to read full article

Pfizer is donating medicines worth more than $70 million to India and is discussing an “expedited approval pathway” for the Pfizer-BioNTech vaccine to help with the Covid-19 situation in the country, Pfizer CEO Albert Bourla said.

Bourla, in a note to Pfizer India colleagues on the Covid-19 situation as shared on LinkedIn, said, “We are committed to being a partner in India's fight against this disease and are quickly working to mobilize the largest humanitarian relief effort in our company's history.”